
HeartBeam Announces Early Completion of HEADSTART-ACS Enrollment in Largest Heart Attack Detection Study Using Its Technology
HeartBeam Completes Enrollment in 486-Patient HEADSTART-ACS Study Ahead of Schedule to Advance 3D ECG Heart Attack Detection Technology HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through advanced cardiac insights, has announced the early completion…














